Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response Using Precision Obesity Test
Source: MyPhenome genetic obesity test
What You Should Know:
– Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.
– The research will evaluate…
Continue Reading